Business Segments MedinCell S.A.

Equities

MEDCL

FR0004065605

Pharmaceuticals

Market Closed - Euronext Paris Other stock markets 11:35:11 2025-01-24 am EST			5-day change	1st Jan Change
15.98 ^EUR	+0.63%		-1.96%	-3.85%

Dec. 13	Eutelsat: delisted from the SBF 120 and CAC Mid 60 indices	CF
Dec. 13	Euroapi: delisted from the SBF 120 and CAC Mid 60 indices	CF

Sales 2024 by Business Segment

See more © MarketScreener.com

Sales 2024 by Geography

See more © MarketScreener.com

Historical Breakdown of Revenue by Business Segments

Net Income: Breakdown by Business Segment

Breakdown by Business Segment (EUR)

Fiscal Period: March	2016	2017	2018	2019	2020	2021	2022	2023	2024
Pharmaceutical Products
Pharmaceuticals					6M	11.78M	4.09M	13.66M	11.94M
Total Assets					27.31M	63.61M	44.3M	29.34M	36.95M
Interest Expense					-2.11M	-3.58M	-1.84M	-3.93M	-4.62M
Income Tax Expense					2.47M	-	-	-	88K
CAPEX					-889K	-819K	-1.97M	-576K	-324K
EBT					-21.44M	-19.02M	-24.81M	-32.01M	-24.95M
D&A					1.04M	1.14M	1.36M	1.5M	1.52M
Operating Income					-19.32M	-15.61M	-23.81M	-24.05M	-20.98M
Net Income					-23.92M	-19.02M	-24.81M	-32.01M	-25.04M

Geographical Revenue Distribution History

Geographical breakdown of sales (EUR)

Fiscal Period: March	2016	2017	2018	2019	2020	2021	2022	2023	2024
Israel					1.34M	4.35M	-	3.16M	5.42M
United States					1.28M	2.54M	2.41M	2.18M	1.63M
Others					228K	1.11M	-	2.57M	1.35M
Switzerland					-	-	1.31M	-	632K
Germany					-	-	368K	1.98M	-
France					-	200K	-	-	-